Michael Verneris
Pediatric Hematology-Oncology · Aurora, CONPI 1336240332
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $41,150 of the $59,708 with a category attached, or 68.9%. 10 manufacturers reported payments, led by Novartis at 39.1% of the total. Reporting peaked in 2021 at $13,037 and has fallen 66.7% since, to $4,345 in 2025. Among pediatric hematology-oncology clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 64 payments — averaging $932.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$23K
- Sanofi-aventis U.S. LLC$18K
- Jazz Pharmaceuticals Inc.$9K
- Mesoblast, Inc.$3K
- Medexus Pharma, Inc.$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- plus $2K from 4 others
Across 21 payments — averaging $4631.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gamida Cell Inc.$47K
- Merck$26K
- National Marrow Donor Program$15K
- Novartis$9K
What the payments were for
- Consulting fees$41,15069%
- Speaking & faculty fees$10,04817%
- Travel & lodging$3,6786%
- Food & beverage$4,8338%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 27 | $23,363 |
| Sanofi-aventis U.S. LLC | 12 | $18,185 |
| Jazz Pharmaceuticals Inc. | 10 | $8,765 |
| Mesoblast, Inc. | 2 | $3,262 |
| Medexus Pharma, Inc. | 2 | $2,205 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,650 |
| National Marrow Donor Program | 5 | $1,526 |
| Adaptive Biotechnologies Corporation | 3 | $606 |
| Syndax Pharmaceuticals, Inc. | 1 | $135 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$59,708 in reported general payments places this provider in the 90th percentile of 60 pediatric hematology-oncology providers in Colorado.
See all pediatric hematology-oncology providers in Colorado →
Other pediatric hematology-oncology in Aurora
- Michael WangAurora$225K
- Lia GoreAurora$68K
- Marilyn Manco JohnsonAurora$67K
- Christopher McKinneyAurora$32K
- Daniel AmbrusoAurora$30K
- Taizo NakanoAurora$24K
- Hesham EissaAurora$23K
- Rachelle NussAurora$23K
- Terry FryAurora$20K
- Christopher NgAurora$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.